Skip to main content

Search form

You are here

Dani Paul Bolognesi, PhD

Professor Emeritus of Surgery
Division: 
Surgical Sciences
Office: 204 Surg Oncol Res Fac, Durham, NC 27710
Campus Mail: DUMC Box 3704 Med Ctr, Durham, NC 27710

Education and Training

  • Ph.D., Duke University, 1967

Selected Grants

Publications

Desjardins, Annick, Matthias Gromeier, James Emmett Herndon, Dina Randazzo, Stevie Threatt, Eric S. Lipp, Elizabeth S. Miller, et al. “Oncolytic polio/rhinovirus recombinant (PVSRIPO) against WHO grade IV malignant glioma (MG): Experience with retreatment of survivors from the phase I trial.” In Journal of Clinical Oncology, 37:101s-101s. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/JCO.2019.37.15_suppl.2060.

Full Text

Desjardins, Annick, Matthias Gromeier, James E. Herndon, Nike Beaubier, Dani P. Bolognesi, Allan H. Friedman, Henry S. Friedman, et al. “Recurrent Glioblastoma Treated with Recombinant Poliovirus.” N Engl J Med 379, no. 2 (July 12, 2018): 150–61. https://doi.org/10.1056/NEJMoa1716435.

Full Text

Gallo, R. C., P. J. Fischinger, and D. P. Bolognesi. “Vaccine strategies against the human retroviruses associated with AIDS.” In Vaccine Intervention Against Virus-Induced Tumour: Leukaemia and Lymphoma Research, 81–91, 2016. https://doi.org/10.1007/978-1-349-08243-8.

Full Text

Lu, Rong-Jian, John A. Tucker, Jason Pickens, You-An Ma, Tatiana Zinevitch, Olga Kirichenko, Vitalii Konoplev, et al. “Heterobiaryl human immunodeficiency virus entry inhibitors.” J Med Chem 52, no. 14 (July 23, 2009): 4481–87. https://doi.org/10.1021/jm900330x.

Full Text

Lu, Rong-Jian, John A. Tucker, Tatiana Zinevitch, Olga Kirichenko, Vitalii Konoplev, Svetlana Kuznetsova, Sergey Sviridov, et al. “Design and synthesis of human immunodeficiency virus entry inhibitors: sulfonamide as an isostere for the alpha-ketoamide group.” J Med Chem 50, no. 26 (December 27, 2007): 6535–44. https://doi.org/10.1021/jm070650e.

Full Text

Matthews, Tom, Miklos Salgo, Michael Greenberg, Jain Chung, Ralph DeMasi, and Dani Bolognesi. “Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes.” Nat Rev Drug Discov 3, no. 3 (March 2004): 215–25. https://doi.org/10.1038/nrd1331.

Full Text

LaBranche, C. C., G. Galasso, J. P. Moore, D. P. Bolognesi, M. S. Hirsch, and S. M. Hammer. “HIV fusion and its inhibition.” Antiviral Res 50, no. 2 (May 2001): 95–115. https://doi.org/10.1016/s0166-3542(01)00130-9.

Full Text

Chen, C. H., M. L. Greenberg, D. P. Bolognesi, and T. J. Matthews. “Monoclonal antibodies that bind to the core of fusion-active glycoprotein 41.” Aids Res Hum Retroviruses 16, no. 18 (December 10, 2000): 2037–41. https://doi.org/10.1089/088922200750054765.

Full Text

Sabbaj, S., M. J. Mulligan, R. H. Hsieh, R. B. Belshe, and J. R. McGhee. “Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine. NIAID AIDS Vaccine Evaluation Group.” Aids, July 7, 2000. https://doi.org/10.1097/00002030-200007070-00009.

Full Text

Pages